Trading in Novo Nordisk shares by board members executives and associated persons on 7 May 2019

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2019

10:22 EDT 9 May 2019 | GlobalNewsWire (2014)

Bagsværd, Denmark, 9 May 2019 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. 
 
The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons. 
 

Further information

Media:    
Mette Kruse Danielsen +45 4442 3883 mkd@novonordisk.com
Ken Inchausti (US) +1 609 240 9429 kiau@novonordisk.com
     
Investors:    
Peter Hugreffe Ankersen +45 3075 9085 phak@novonordisk.com
Valdemar Borum Svarrer +45 3079 0301 jvls@novonordisk.com
Ann Søndermølle Rendbæk +45 3075 2253 arnd@novonordisk.com
Kristoffer Due Berg (US) +1 609 235 2989 krdb@novonordisk.com
 
 
Company announcement No 33 / 2019
Company announcement No 33 / 2019


This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire

More From BioPortfolio on "Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2019"